אייסנטרס 400 מ"ג טבליות

Nazione: Israele

Lingua: ebraico

Fonte: Ministry of Health

Principio attivo:

RALTEGRAVIR AS POTASSIUM 400 MG

Commercializzato da:

MERCK SHARP & DOHME ISRAEL LTD

Codice ATC:

J05AX08

Forma farmaceutica:

TABLETS

Via di somministrazione:

PER OS

Prodotto da:

MERCK SHARP & DOHME B.V, HOLLAND

Gruppo terapeutico:

RALTEGRAVIR

Indicazioni terapeutiche:

ISENTRESS is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (HIV-1) infection in adult patients.This indication is based on safety and efficacy data from two double-blind, placebo-controlled trials in treatment-experienced patients and one double-blind, active-controlled trial in treatment-naive patients.

Data dell'autorizzazione:

2009-03-01